Filing Details

Accession Number:
0001209191-11-048386
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-19 17:06:05
Reporting Period:
2011-09-15
Filing Date:
2011-09-19
Accepted Time:
2011-09-19 17:06:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411861 Mako Surgical Corp. MAKO Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 201901148
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1462368 Ivan Delevic C/O Mako Surgical Corp.
2555 Davie Road
Fort Lauderdale FL 33317
Svp Strategic Mktg&Bus Develop No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-15 12,000 $6.90 13,815 No 4 M Direct
Common Stock Disposition 2011-09-15 12,000 $37.72 1,815 No 4 S Direct
Common Stock Acquisiton 2011-09-19 2,000 $6.90 3,815 No 4 M Direct
Common Stock Disposition 2011-09-19 2,000 $38.10 1,815 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2011-09-15 12,000 $0.00 12,000 $6.90
Common Stock Employee Stock Option (Right to Buy) Disposition 2011-09-19 2,000 $0.00 2,000 $6.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
73,500 2019-04-27 No 4 M Direct
71,500 2019-04-27 No 4 M Direct
Footnotes
  1. Includes 1,815 shares acquired under the issuer's 2008 Employee Stock Purchase Plan.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2011.
  3. The price in Column 4 is a weighted average price per share. The shares were sold in multiple transactions at prices ranging from $37.01 to $38.06 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
  4. Vests and becomes exercisable ratably quarterly over four years commencing on the grant date.